Jules G Becher Selected Research

Cerebral Palsy (Spastic Diplegia)

4/2022	Attainment of personal goals in the first year of intrathecal baclofen treatment in dyskinetic cerebral palsy: a prospective cohort study.
1/2019	Effect of continuous intrathecal baclofen therapy in children: a systematic review.
1/2019	The Effect of Intrathecal Baclofen in Dyskinetic Cerebral Palsy: The IDYS Trial.
10/2018	Improved parent-reported mobility and achievement of individual goals on activity and participation level after functional power-training in young children with cerebral palsy: a double-baseline controlled trial.
2/2018	Measuring wearing time of knee-ankle-foot orthoses in children with cerebral palsy: comparison of parent-report and objective measurement.
9/2017	Improved Walking Capacity and Muscle Strength After Functional Power-Training in Young Children With Cerebral Palsy.
1/2017	Isometric muscle strength and mobility capacity in children with cerebral palsy.
12/2016	Botulinum neurotoxin treatment in children with cerebral palsy: validation of a needle placement protocol using passive muscle stretching and relaxing.
1/2016	An individual approach for optimizing ankle-foot orthoses to improve mobility in children with spastic cerebral palsy walking with excessive knee flexion.
1/2016	Cerebral palsy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jules G Becher Research Topics

Disease

34	Cerebral Palsy (Spastic Diplegia) 04/2022 - 05/2005
7	Dystonia (Limb Dystonia) 04/2022 - 11/2011
5	Muscle Spasticity (Spastic) 12/2016 - 05/2009
2	Pain (Aches) 04/2022 - 11/2011
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2019
1	Muscular Diseases (Myopathy) 09/2010
1	Paresis (Hemiparesis) 02/2010
1	Movement Disorders (Movement Disorder) 01/2010
1	Dyskinesias (Dyskinesia) 10/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2008
1	Disease Progression 07/2008

Drug/Important Bio-Agent (IBA)

7	Baclofen FDA LinkGeneric 04/2022 - 05/2009
6	Type A Botulinum Toxins (Botox)FDA Link 12/2016 - 05/2005
2	Botulinum Toxins (Botulinum Toxin)IBA 12/2016 - 01/2010
1	benzoylamido- 4'- aminostilbene- 2,2'- disulfonate (BADS)IBA 01/2020
1	incobotulinumtoxinA FDA Link 12/2016
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2016
1	Oxygen (Dioxygen)IBA 01/2014
1	CP 14IBA 01/2010

Therapy/Procedure

11	Rhizotomy 01/2018 - 06/2005
7	Foot Orthoses 02/2018 - 09/2010
5	Resistance Training 10/2018 - 10/2008
4	Therapeutics 01/2019 - 05/2009
2	Injections 06/2008 - 05/2006
1	Aftercare (After-Treatment) 01/2020
1	Activities of Daily Living (ADL) 10/2018
1	Orthotic Devices (Orthosis) 02/2013
1	Splints (Splint) 03/2012